Skip to main content

Advertisement

Log in

Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Howlett NG, Taniguchi T, Olson S et al (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606–609

    Article  CAS  PubMed  Google Scholar 

  2. Xia B, Dorsman JC, Ameziane N et al (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159–161

    Article  CAS  PubMed  Google Scholar 

  3. Levran O, Attwooll C, Henry RT et al (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37:931–933

    Article  CAS  PubMed  Google Scholar 

  4. Vaz F, Hanenberg H, Schuster B et al (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42:406–409

    Article  CAS  PubMed  Google Scholar 

  5. Kiiski JI, Pelttari LM, Khan S et al (2014) Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci U S A 111:15172–15177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U (2014) Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. Breast Cancer Res Treat 145:775–784

    Article  CAS  PubMed  Google Scholar 

  7. Rashid MU, Zaidi A, Torres D et al (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119:2832–2839

    Article  CAS  PubMed  Google Scholar 

  8. Garcia MJ, Fernandez V, Osorio A et al (2009) Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 30:1898–1902

    Article  CAS  PubMed  Google Scholar 

  9. Gracia-Aznarez FJ, Fernandez V, Pita G et al (2013) Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS One 8:e55681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Akbari MR, Malekzadeh R, Lepage P et al (2011) Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet 129:573–582

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to all patients and healthy controls for their participation in this study. We thank Heli Nevanlinna for DNA samples of FANCM c.5101C>T mutation carriers. We thank Iqbal U. Ali for critical review of the manuscript. This work was supported by the SKMCH & RC, Lahore, Pakistan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad U. Rashid.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashid, M.U., Muhammad, N., Khan, F.A. et al. Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan. Breast Cancer Res Treat 152, 229–230 (2015). https://doi.org/10.1007/s10549-015-3457-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3457-5

Keywords

Navigation